3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
564
Expanded_access
3
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thalassemia
1
Immunologic Deficiency Syndromes
1
Hemoglobinopathies
1
Hematologic Neoplasms
1
Fanconi Anemia
1
Anemia, Sickle Cell
1
Interventions
Surveys and Questionnaires
529
Blood Specimen Collection
405
Surgical Procedures, Operative
151
Interviews as Topic
131
Radiotherapy
130
Observation
122
Drug Therapy
122
Magnetic Resonance Spectroscopy
104
Biopsy
103
Specimen Handling
70
Data Collection
70
Neoadjuvant Therapy
65
Immunohistochemistry
64
Magnetic Resonance Imaging
61
Immune Checkpoint Inhibitors
58
Watchful Waiting
51
Immunotherapy
51
Bevacizumab
49
Positron Emission Tomography Computed Tomography
46
Ultrasonography
44
Liquid Biopsy
41
Hematologic Tests
41
Tomography, X-Ray Computed
40
Therapeutics
40
Radiosurgery
40
Colonoscopy
40
pembrolizumab
37
Hepatectomy
37
Gene Expression Profiling
36
High-Energy Shock Waves
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
fludarabine phosphate
×
Clear all
NCT01316549
2021-10-04
HCT
University of California, San Francisco
Completed
67 enrolled